BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12047794)

  • 21. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
    Kwiterovich PO
    Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertriglyceridemia and coronaryheart disease risk.
    Rosenson RS
    Cardiol Rev; 1999; 7(6):342-8. PubMed ID: 11208246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertriglyceridemia: concept and clinical significance].
    Hirano T
    Nihon Rinsho; 2013 Sep; 71(9):1519-27. PubMed ID: 24205709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triglycerides and coronary risk.
    Gaziano JM
    Curr Cardiol Rep; 1999 Jul; 1(2):125-30. PubMed ID: 10980831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease.
    Sprecher DL; Watkins TR; Behar S; Brown WV; Rubins HB; Schaefer EJ
    Am J Cardiol; 2003 Mar; 91(5):575-80. PubMed ID: 12615263
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease.
    Dobiasova M; Stribrna J; Sparks DL; Pritchard PH; Frohlich JJ
    Arterioscler Thromb; 1991; 11(1):64-70. PubMed ID: 1988005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.
    Maki KC; Galant R; Davidson MH
    Am J Cardiol; 2005 Nov; 96(9A):59K-64K; discussion 34K-35K. PubMed ID: 16291016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease.
    Lavie CJ; Milani RV
    Am J Cardiol; 1994 Dec; 74(12):1192-5. PubMed ID: 7977088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertriglyceridemia as a possible independent risk factor for stroke.
    Lisak M; Demarin V; Trkanjec Z; Basić-Kes V
    Acta Clin Croat; 2013 Dec; 52(4):458-63. PubMed ID: 24696996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalisation of the composition of very low density lipoprotein in hypertriglyceridemia by nicotinic acid.
    Tornvall P; Hamsten A; Johansson J; Carlson LA
    Atherosclerosis; 1990 Oct; 84(2-3):219-27. PubMed ID: 2282100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-HDL cholesterol as a measure of atherosclerotic risk.
    Packard CJ; Saito Y
    J Atheroscler Thromb; 2004; 11(1):6-14. PubMed ID: 15067193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes.
    Hermans MP; Valensi P
    Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):118-129. PubMed ID: 29493554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.